Multimodality approach to early-stage non-small cell lung cancer

Lung Cancer

Volumn 57, Issue SUPPL. 2, 2007, Pages

  Scagliotti, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Adjuvant chemotherapy; Early stage non small cell lung cancer; Gene expression analysis; Patient selection; Pharmacogenomics

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; CYANOCOBALAMIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FOLIC ACID; GEMCITABINE; IFOSFAMIDE; LOW MOLECULAR WEIGHT HEPARIN; MITOMYCIN; NAVELBINE; PACLITAXEL; PEMETREXED; PLACEBO; RIBONUCLEOTIDE REDUCTASE; SIALOPROTEIN; TAXANE DERIVATIVE; UFT;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEBRILE NEUTROPENIA; GENE EXPRESSION; GENE MUTATION; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; NEUTROPENIA; OVERALL SURVIVAL; PHARMACOGENOMICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; HUMANS; LUNG NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING;

EID: 34547570975     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(07)70421-X     Document Type: Article

References (17)

1. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 311 (1995) 899-909
2. Scagliotti G., Fossati R., Torri V., et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 95 (2003) 1453-1461
3. Arriagada R., Bergman B., Dunant A., et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
4. Winton T., Livingston R., Johnson D., et al. Vinorelbine and cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352 (2005) 2589-2597
5. Strauss G., Herndon J., Maddaus M., et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer And Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 24 18S (2006) 7007
6. Douillard J., Rosell R., De Lena M., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7 (2006) 719-727
7. Pignon J., Tribodet H., Scagliotti G., et al. Lung adjuvant cisplatin evaluation (LACE): a pooled analysis of five randomized clinical trials including 4,584 patients. J Clin Oncol 24 18S (2006) 7008
8. Waller D., Peake M., Stephens R., et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 26 (2004) 173-182
9. Hamada C., Tanaka F., Ohta M., et al. Meta-analysis of postoperative adjuvant chemotherapy with tagfur-uracil in non-smallcell lung cancer. J Clin Oncol 23 (2005) 4999-5006
10. Papotti M., Kalebic T., Volante M., et al. Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study. J Clin Oncol 24 (2006) 4818-4824
11. Bepler G. Pharmacogenomics: a reality or still a promise?. Lung Cancer 54 Suppl 2 (2006) S3-S7
12. Danesi R., De Braud F., Fogli S., et al. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer. Pharmacol Rev 55 (2003) 57-103
13. Ceppi P., Volante M., Novello S., et al. ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Ann Oncol 17 (2006) 1818-1825
14. Olaussen K., Dunant A., Fouret P., et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355 (2006) 983-991
15. Potti A., Mukherjee S., Petersen R., et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 355 (2006) 570-580
16. Depierre A., Milleron B., Moro-Sibilot, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2002) 247-253
17. Pisters K., Vallieres P., Bunn J., et al. S9900: a phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): preliminary results. J Clin Oncol 23 16S (2005) LBA 7012